KalVista Pharmaceuticals, Inc.
KALV
$27.00
$0.010.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 07/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.49M | -5.37M | -- | -60.10M | -51.84M |
| Total Depreciation and Amortization | 355.00K | 586.50K | -- | 252.00K | 251.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.86M | 22.32M | -- | 10.04M | 2.61M |
| Change in Net Operating Assets | -4.18M | -12.98M | -- | -4.70M | 1.41M |
| Cash from Operations | -14.46M | 4.55M | -- | -54.50M | -47.57M |
| Capital Expenditure | -121.00K | -697.50K | -- | -290.00K | -288.00K |
| Sale of Property, Plant, and Equipment | -- | -12.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -780.00K | 8.86M | -- | 21.55M | -3.43M |
| Cash from Investing | -901.00K | 8.15M | -- | 21.26M | -3.72M |
| Total Debt Issued | -- | 69.14M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.47M | -- | -- | 1.29M | 2.22M |
| Repurchase of Common Stock | -- | -810.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 11.25M | -- | 21.92M | -- |
| Cash from Financing | 1.47M | 79.57M | -- | 23.21M | 2.22M |
| Foreign Exchange rate Adjustments | -1.68M | -6.79M | -- | 2.72M | 2.24M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.57M | 85.49M | -- | -7.31M | -46.82M |